CPH2 must secure new revenue or investment from its hydrogen electrolyser technology to remain solvent beyond the second half of 2025.
In its 2024 financial results, the UK-based technology firm revealed a £14.4m ($19m) loss, significantly worse than the year prior at £4.1m ($5.5m). Ultimately, its cash at year end stood at £300,000 ($400,000), down from £8.5m ($11.3m) in 2023.
While a £5.7m ($7.6m) equity raise in January 2025 helped temporarily, CPH2 has admitted it needs more funding in the second half of the year to stay afloat.
… to continue reading this article and more, please login, register for free, or consider subscribing to H2 View
